Rishi P. Singh, MD

home / authors / rishi-p-singh-md

Articles

Patient Selection for Biosimilars

Rishi P. Singh, MD

November 28th 2023

Rishi Singh, MD, discusses the criteria for identifying patients who would benefit from biosimilar therapy.

Visual and Anatomic Improvement with a Ranibizumab Biosimilar

Rishi P. Singh, MD

November 28th 2023

Rishi Singh, MD, presents a case of neovascular age-related macular degeneration and diabetic macular edema demonstrating how the use of ranibizumab biosimilars can yield remarkable anatomical improvements comparable to those expected with reference biologics.

Overview of Biosimilars for Treating Retinal Diseases

Rishi P. Singh, MD

November 28th 2023

Rishi Singh, MD, provides an overview of biosimilars in the context of retinal diseases and discusses their significance within the healthcare system.

DR/DME: Ongoing Clinical Trials and New Diagnostic Tools

Carolyn Majcher, OD, FAAO;Rishi P. Singh, MD

February 17th 2023

Carolyn Majcher, OD, FAAO, and Rishi Singh, MD, discuss new and upcoming clinical trials, investigational therapies, and diagnostic tools for the treatment of diabetic retinopathy and diabetic macular edema (DR/DME).

Reducing Treatment Burden of DR/DME

Carolyn Majcher, OD, FAAO;Rishi P. Singh, MD

February 17th 2023

Diabetic retinal disease experts discuss different approaches that can reduce the treatment burden while maintaining good visual outcomes during diabetic retinopathy and diabetic macular edema (DR/DME) therapy.

Available Treatments for DR/DME

Carolyn Majcher, OD, FAAO;Rishi P. Singh, MD

February 17th 2023

Rishi Singh, MD, provides an overview of the various treatment options available for diabetic retinopathy and diabetic macular edema (DR/DME).

Referring Patients With DR/DME to a Retina Specialist

Carolyn Majcher, OD, FAAO;Rishi P. Singh, MD

February 10th 2023

Carolyn Majcher, OD, FAAO, discusses when to refer patients with diabetic retinopathy and diabetic macular edema (DR/DME) to a retina specialist.

Diagnostic Challenges of DR/DME

Carolyn Majcher, OD, FAAO;Rishi P. Singh, MD

February 3rd 2023

Carolyn Majcher, OD, FAAO, describes challenges primary eye care providers can experience when diagnosing diabetic retinopathy and diabetic macular edema (DR/DME).

Multimodal Imaging for DR/DME

Carolyn Majcher, OD, FAAO;Rishi P. Singh, MD

February 3rd 2023

Diabetic retinal disease experts discuss the standard diagnostic imaging tools that are available to detect diabetic retinopathy and diabetic macular edema (DR/DME).

Symptoms of DR/DME and Recommendations

Carolyn Majcher, OD, FAAO;Rishi P. Singh, MD

January 27th 2023

Carolyn Majcher, OD, FAAO, provides an overview of the symptoms of diabetic retinopathy and diabetic macular edema (DR/DME) and recommendations for dilated eye exams for patients with type 1 and type 2 diabetes.

Prevalence of DR/DME and Impact of Early Diagnosis

Carolyn Majcher, OD, FAAO;Rishi P. Singh, MD

January 27th 2023

Carolyn Majcher, OD, FAAO, and Rishi Singh, MD, discuss the current prevalence and future projections of diabetic retinopathy and diabetic macular edema (DR/DME) as well as the impact of early diagnosis and treatment for patients with diabetic retinal diseases.